You are here

Boston Children’s Hospital

300 Longwood Avenue
Boston, MA 02115
United States

Alveolar rhabdomyosarcoma is an aggressive childhood cancer, and many children with this disease carry a mutation that combines two different proteins, PAX3 and FOXO1, into one protein, PAX3-FOXO1. This creates a protein with new function, causing changes in gene expression that leads to cancer. Children with this mutation face poor outcomes. This fusion protein is highly dynamic and samples many different structures, too many to reasonably count in fact. This makes the protein hard to drug because we traditionally target stably folded regions of proteins.

Boston Children’s Hospital

Mentor Name: Leonard Zon

Boston Children’s Hospital
Boston Children’s Hospital
Boston Children’s Hospital
Boston Children’s Hospital

Background

The LIN28 family of RNA binding proteins are known drivers of many pediatric cancers. These proteins function by blocking the function of the let-7 family of microRNAs, which exert tumor suppressive effects. To date, despite the panoply of childhood tumors driven by LIN28, efforts to target this protein in pediatric cancer are lacking.

Choroid plexus carcinoma (CPC) is a rare, aggressive brain cancer arising from the choroid plexus (ChP), a highly complex tissue within the brain's ventricles that produces cerebrospinal fluid. CPC is most often diagnosed in young children, and the only hope for survival is usually total removal of the tumor through surgery. However, this surgery is often complicated due to large tumor size at diagnosis, tumor invasion of nearby brain tissue, and complicated networks of blood vessels in CPC that bleed significantly in the operating room.

Although there have been significant strides made in treating pediatric cancer, a large number of children still succumb to their disease. Moreover, survivors can have detrimental late effects from their chemotherapy and radiation including abnormal growth and development and acquisition of secondary cancers. Therefore, improved and less toxic treatments are urgently needed. A common event leading to pediatric cancer is the breakage of two chromosome and swapping of genetic material between ends.

Pages